Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Eli Lilly & Co.

NYS: LLY

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Eli Lilly & Co.

After Hours

LLY
/zigman2/quotes/200106384/composite

$

162.10

Change

+0.02 +0.01%

Volume

Volume 229,390

Jul 13, 2020, 7:47 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200106384/composite

Previous close

$ 163.36

$ 162.08

Change

-1.28 -0.78%

Day low

Day high

$161.04

$167.00

Open
Open: 164.61

52 week low

52 week high

$101.36

$170.75

Open

Market cap

$156.34B

Average volume

3.65M

P/E ratio

26.84

Rev. per Employee

$634,842

EPS

6.04

Dividend

0.74

Div yield

1.83%

Ex dividend date

5/14/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lly

MarketWatch News on LLY

  1. Regeneron Is Up as Covid-19 Drug Moves Into Phase 3 Tests

    10:43 a.m. July 6, 2020

    - Josh Nathan-Kazis

  2. Covid Cases Are Surging. Here’s What Comes Next.

    4:37 p.m. July 2, 2020

    - Josh Nathan-Kazis

  3. These 5 Dividend Funds Offer the Flexibility to Weather the Pandemic

    8:30 a.m. July 2, 2020

    - Lawrence C. Strauss

  6. How to Play Biotech’s Next Rise

    9:48 a.m. June 20, 2020

    - Ben Levisohn

  7. A Stockpicker on the Reshaping of Health Care

    4:12 p.m. June 18, 2020

    - Leslie P. Norton

  8. Eli Lilly stock price target raised to $190 from $175 at J.P. Morgan

    7:32 a.m. June 17, 2020

    - Tomi Kilgore

  14. Eli Lilly's Olumiant is approved in 70 countries to treat rheumatoid arthritis

    6:50 a.m. June 15, 2020

    - Tomi Kilgore

  15. Eli Lilly enrolls first patient in phase 3 trial of Olumiant for hospitalized patients with COVID-19

    6:49 a.m. June 15, 2020

    - Tomi Kilgore

  18. Antibody Drugs Could Help Curb the Pandemic

    1:22 p.m. June 5, 2020

    - Josh Nathan-Kazis

  20. Buy Lilly, AbbVie and Merck, J.P. Morgan Says

    9:16 a.m. June 2, 2020

    - Bill Alpert

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/lly

Other News on LLY

  1. Top Stocks To Buy On A Sell-Off

    11:29 a.m. July 13, 2020

    - Seeking Alpha

  2. Demand for Chief Diversity Officers Is High. So Is Turnover.

    7:00 a.m. July 13, 2020

    - Chip Cutter

  5. Insiders Roundup: Mastercard, Eli Lilly

    9:11 a.m. July 10, 2020

    - GuruFocus.com

  10. Immunomedics: A Solid Cancer Research Play

    9:29 a.m. July 8, 2020

    - GuruFocus.com

  12. U.S. Virus Cases Rise as Country Withdraws From WHO

    6:28 p.m. July 7, 2020

    - Talal Ansari

  14. 5 Companies Reach 52-Week Highs

    9:40 a.m. July 7, 2020

    - GuruFocus.com

  17. Regeneron Advances Covid-19 Drug Into Later-Stage Testing

    12:10 p.m. July 6, 2020

    - Joseph Walker

  20. Top 10 Healthcare Stocks For Dividend Growth And Income

    9:01 a.m. July 6, 2020

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/lly

Press Releases on LLY

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.